Gallia Levy

Chief Tech/Sci/R&D Officer presso SPARK THERAPEUTICS, INC.

Health Technology

Profilo

Gallia G.
Levy is currently the Chief Medical & Strategy Officer at Spark Therapeutics, Inc. Prior to this, she worked as an Associate Group Medical Director at Genentech, Inc. and as an Associate Group Medical Director-Hematology at Roche Holding AG.

Posizioni attive di Gallia Levy

Società	Posizione	Inizio
SPARK THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

Tutte le posizioni attive di Gallia Levy

Precedenti posizioni note di Gallia Levy

Società	Posizione	Fine
ROCHE HOLDING AG	Corporate Officer/Principal	-
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	-

Vedi nel dettaglio l'esperienza di Gallia Levy

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gallia Levy

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ROCHE HOLDING AG	Health Technology

Aziende private	2
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
Spark Therapeutics, Inc. Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.	Health Technology